GSK Hits Consumer Brand Divestment Target As Q3 Performance Mixed
GSK's Brian McNamara says the firm has hit its £1bn brand divestment target which will help fund the restructuring of its Consumer Healthcare business before it is spun off in 2022.
You may also be interested in...
Major Europe-based consumer health players GSK, Sanofi, Bayer and Reckitt continue to deal with the fallout of the COVID-19 pandemic while implementing long-term strategies to drive growth. This earnings preview highlights what to look out for as these four firms report their third-quarter results over the coming weeks.
GSK divests non-core German OTC portfolio to local player PharmaSGP, which says it has gained "established brands" in the pain-relief and sleep-aid categories.
HBW Insight reveals the biggest consumer health deals of 2020, and identifies growing private equity investment, portfolio streamlining by major players and pharma firms exiting OTC as the major drivers of M&A activity.